Albuminuria in Type 1 diabetes is not only a sign of kidney disease but also an independent risk factor for proliferative retinopathy and macroangiopathy. The study suggests that albuminuria reflects widespread vascular damage, which is linked to renal and extrarenal complications. The process begins shortly after diabetes onset, with albuminuria increasing exponentially in some patients. The study highlights that albuminuria is associated with poor prognosis and is not solely due to poor blood sugar control. Instead, it is linked to generalized vascular dysfunction, including increased permeability and endothelial damage. The study also suggests that genetic factors play a role in the development of albuminuria, as evidenced by differences in susceptibility among individuals. The loss of heparan sulphate proteoglycan, a key component of the extracellular matrix, is implicated in the pathogenesis of albuminuria and its complications. This loss leads to reduced negative charges in the extracellular matrix, contributing to increased vascular permeability and the progression of kidney disease, retinopathy, and macroangiopathy. The study concludes that albuminuria reflects widespread vascular damage and that genetic polymorphism in enzymes involved in heparan sulphate metabolism may explain the variability in disease progression among patients with Type 1 diabetes.Albuminuria in Type 1 diabetes is not only a sign of kidney disease but also an independent risk factor for proliferative retinopathy and macroangiopathy. The study suggests that albuminuria reflects widespread vascular damage, which is linked to renal and extrarenal complications. The process begins shortly after diabetes onset, with albuminuria increasing exponentially in some patients. The study highlights that albuminuria is associated with poor prognosis and is not solely due to poor blood sugar control. Instead, it is linked to generalized vascular dysfunction, including increased permeability and endothelial damage. The study also suggests that genetic factors play a role in the development of albuminuria, as evidenced by differences in susceptibility among individuals. The loss of heparan sulphate proteoglycan, a key component of the extracellular matrix, is implicated in the pathogenesis of albuminuria and its complications. This loss leads to reduced negative charges in the extracellular matrix, contributing to increased vascular permeability and the progression of kidney disease, retinopathy, and macroangiopathy. The study concludes that albuminuria reflects widespread vascular damage and that genetic polymorphism in enzymes involved in heparan sulphate metabolism may explain the variability in disease progression among patients with Type 1 diabetes.